Chimerix, Inc. logo

Chimerix, Inc.

NASDAQ:CMRX

Overview | Financials
Company Name Chimerix, Inc.
Symbol CMRX
Currency USD
Price 0.872
Market Cap 78,191,751
Dividend Yield 0%
52-week-range 0.75 - 1.3
Industry Biotechnology
Sector Healthcare
CEO Mr. Michael T. Andriole M.B.A.
Website https://www.chimerix.com

An error occurred while fetching data.

About Chimerix, Inc.

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a

Related Stocks

Biomea Fusion, Inc. logo

Biomea Fusion, Inc.

BMEA

11.42 USD

Longeveron Inc. logo

Longeveron Inc.

LGVN

2.21 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

2.39 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

0.75 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

5.15 USD

High Tide Inc. logo

High Tide Inc.

HITI

2.55 USD

Financials

Numbers are in millions USD

Numbers are in millions USD